HK1108368A1 - Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation - Google Patents

Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation

Info

Publication number
HK1108368A1
HK1108368A1 HK07113627.7A HK07113627A HK1108368A1 HK 1108368 A1 HK1108368 A1 HK 1108368A1 HK 07113627 A HK07113627 A HK 07113627A HK 1108368 A1 HK1108368 A1 HK 1108368A1
Authority
HK
Hong Kong
Prior art keywords
preparation
phytosterol
diglyceride
delivery
metal cations
Prior art date
Application number
HK07113627.7A
Other languages
English (en)
Inventor
Jean-Claude Maurel
Original Assignee
Medesis Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medesis Pharma filed Critical Medesis Pharma
Publication of HK1108368A1 publication Critical patent/HK1108368A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Psychology (AREA)
HK07113627.7A 2004-11-02 2007-12-13 Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation HK1108368A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04025987A EP1652512A1 (en) 2004-11-02 2004-11-02 Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation
PCT/IB2005/003605 WO2006048773A1 (en) 2004-11-02 2005-11-02 Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation

Publications (1)

Publication Number Publication Date
HK1108368A1 true HK1108368A1 (en) 2008-05-09

Family

ID=34927200

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07113627.7A HK1108368A1 (en) 2004-11-02 2007-12-13 Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation

Country Status (17)

Country Link
US (1) US9173838B2 (ru)
EP (2) EP1652512A1 (ru)
JP (1) JP4975631B2 (ru)
CN (1) CN101102751B (ru)
AT (1) ATE483454T1 (ru)
AU (1) AU2005300253B2 (ru)
CA (1) CA2584684C (ru)
DE (1) DE602005024036D1 (ru)
DK (1) DK1807048T3 (ru)
EA (1) EA012210B1 (ru)
ES (1) ES2353804T3 (ru)
HK (1) HK1108368A1 (ru)
IL (1) IL182756A (ru)
PL (1) PL1807048T3 (ru)
PT (1) PT1807048E (ru)
WO (1) WO2006048773A1 (ru)
ZA (1) ZA200704286B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1652513A1 (en) * 2004-11-02 2006-05-03 Denderah Pharm Sa Reverse micelles based on sterols and acylglycerols and therapeutic uses thereof
DK2550020T3 (en) 2010-03-24 2015-10-05 Medesis Pharma REVERSE MICELLE MICROEMULSION, INCLUDING METAL IONS AND USES THEREOF
BRPI1000970A2 (pt) * 2010-04-07 2011-11-29 Fundacao Arnaldo Vieira De Carvalho composição farmacêutica para o tratamento da doença de alzheimer, processo para sua obtenção e uso
WO2012007387A1 (en) * 2010-07-13 2012-01-19 Medesis Pharma Low- dose lithium for the treatment of neurodegenerative disorders
WO2017005899A1 (en) * 2015-07-09 2017-01-12 Medesis Pharma In situ preparation of cyano-bridged metal nanop articles within a biocompatible reverse micellar system
AU2019298653A1 (en) * 2018-07-06 2021-01-14 Medesis Pharma Treatment and prevention of injury due to radiation exposure

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252333A (en) * 1987-04-27 1993-10-12 Scotia Holdings Plc Lithium salt-containing pharmaceutical compositions
FR2658816A1 (fr) * 1990-02-27 1991-08-30 Adir Nouveaux sels de metaux alcalinoterreux d'oxa-polyacides leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2729957B1 (fr) 1995-01-31 1997-12-05 Maurel Sante Complexes organometalliques a base de sitosterols et d'acylglycerols et compositions pharmaceutiques et produits dietetiques en contenant.
FR2750606B1 (fr) * 1996-07-03 1999-01-29 Maurel Sante Complexes organometalliques a base de sitosterols et de diglycerides et compositions pharmaceutiques en contenant
JPH119988A (ja) * 1997-06-26 1999-01-19 Advanced Sukin Res Kenkyusho:Kk 油中水型マイクロエマルション
JPH1129464A (ja) * 1997-07-07 1999-02-02 Advanced Sukin Res Kenkyusho:Kk コレステロールを添加する油中水型マイクロエマルション
WO2000057721A2 (en) * 1999-03-26 2000-10-05 Akesis Pharmaceuticals, Inc. Edible solids for treatment of glucose metabolism disorders
US6623765B1 (en) * 2000-08-01 2003-09-23 University Of Florida, Research Foundation, Incorporated Microemulsion and micelle systems for solubilizing drugs
US6365176B1 (en) * 2000-08-08 2002-04-02 Functional Foods, Inc. Nutritional supplement for patients with type 2 diabetes mellitus for lipodystrophy
ATE390849T1 (de) * 2001-01-25 2008-04-15 Unilever Nv Mikroemulsionen
US20030113366A1 (en) * 2001-12-14 2003-06-19 Macgregor Alexander Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
EP1452175A1 (en) * 2003-02-28 2004-09-01 Medesis Pharma S.A. Manganese based organometallic complexes, pharmaceutical compositions and dietetic products
CN1457773A (zh) * 2003-06-02 2003-11-26 乐益 治疗糖尿病的双胍钒络合物颗粒剂和/或胶囊剂及其用途
EP1652513A1 (en) * 2004-11-02 2006-05-03 Denderah Pharm Sa Reverse micelles based on sterols and acylglycerols and therapeutic uses thereof

Also Published As

Publication number Publication date
DK1807048T3 (da) 2011-01-10
ZA200704286B (en) 2008-09-25
JP4975631B2 (ja) 2012-07-11
JP2008519026A (ja) 2008-06-05
AU2005300253A1 (en) 2006-05-11
EA200700994A1 (ru) 2007-10-26
CA2584684A1 (en) 2006-05-11
AU2005300253B2 (en) 2010-09-09
PL1807048T3 (pl) 2011-03-31
US9173838B2 (en) 2015-11-03
CN101102751A (zh) 2008-01-09
EP1652512A1 (en) 2006-05-03
CA2584684C (en) 2013-07-02
ES2353804T3 (es) 2011-03-07
IL182756A0 (en) 2007-07-24
ATE483454T1 (de) 2010-10-15
US20090087477A1 (en) 2009-04-02
EP1807048A1 (en) 2007-07-18
WO2006048773A1 (en) 2006-05-11
EP1807048B1 (en) 2010-10-06
DE602005024036D1 (de) 2010-11-18
CN101102751B (zh) 2011-08-24
PT1807048E (pt) 2010-11-29
IL182756A (en) 2011-02-28
EA012210B1 (ru) 2009-08-28

Similar Documents

Publication Publication Date Title
HK1108368A1 (en) Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation
WO2007110411A3 (en) Whey protein micelles
EP2462924A3 (en) Improvements in or relating to amphoteric liposomes.
WO2005067898A3 (en) Improved sustained release compositions for pulmonary administration of insulin
MX2010006199A (es) Composicion nutricional enterica liquida basada en caseina micelar, densa en cuanto a proteina.
MXPA05009933A (es) Composiciones que comprenden acidos grasos y aminoacidos.
IL247486B (en) A composition comprising nanoparticles comprising docetaxel, albumin and citrate, uses thereof, a method for it's preparation and a sealed vial and a kit comprising the composition
IL190646A (en) Multifunctional June Liquid Preparations, Including Pharmaceutical, Bioactive, Nutritional and Energetic Vehicles and Method for Preparing
IL198612A (en) @Human ligand @ ligand @@@ human delta-like method, method of making them, preparations containing them and using them @ making @ drugs
TWI256891B (en) 17alpha-alkyl-17beta-oxy-estratrienes and intermediate products for their production, use of the 17alpha-alkyl-17beta-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations
EP2045900A3 (en) Flux-switching machine
CA2590433A1 (en) Multi-phase personal care composition comprising visually distinct phases
WO2005079396A3 (en) O,o'-amidomalonate and n,o-amidomalonate platinum complexes
WO2009050580A8 (fr) Composition destinee a la regulation du metabolism des lipides
PL368976A1 (en) Composition for lowering blood cholesterol
TW200603746A (en) Iron sulfate based phosphate adsorbent
HK1083296A1 (en) Enteral composition for the prevention and/or treatment of sepsis
TW200630343A (en) 2-Alkoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
WO2008063808A3 (en) Encapsulated peptide amphiphile nanostructures
WO2008011272A3 (en) Liquid monophasic lipid-soluble antioxidant compositions and processes for making the compositions
PL1742927T3 (pl) Pochodne kwasu butanowego, sposoby ich otrzymywania, kompozycje farmaceutyczne zawierające takie pochodne i terapeutyczne zastosowanie takich pochodnych
WO2008070141A3 (en) Compositions for delivery of therapeutic agents
WO2006129095A3 (en) Sustained release preparations of pro-insulin c-peptide
EP2251004A3 (fr) Composition pharmaceutique ou cosmétique, et procédé de solubilisation mixte pour préparer la composition
WO2003105765A3 (en) PHOSPHOLIPIDIC MICELLES IN LIPOSOMES AS SOLUBILIZING AGENTS FOR WATER-INSOLUBLE COMPOUNDS

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20181102